Search results for "Paroxysmal"

showing 10 items of 64 documents

Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs

2017

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disorder characterized by hemolytic anemia, bone marrow failure and thrombosis, caused by a somaticmutation in PIG-A gene that results in theabsence of CD55 and CD59, two important complement regulatory proteins. In thispaper, a case of PNH is retrospectively examined looking for clinical and laboratory features, and the entire course of the disease from the onset of the symptoms isdescribed, together with an adequate follow-up over a 7-years treatment period. Inthis case, the not specificity and the limited clinical relevance of the symptoms led to adelay in diagnosis. After thrombosis, Eculizumab therapy has been shown to be effec…

0301 basic medicineHemolytic anemiaPediatricsmedicine.medical_specialtyrenal failureParoxysmal nocturnal haemoglobinuriaparoxysmal nocturnal hemoglobinuriaCase ReportDiseaseCD5903 medical and health sciencesthrombotic eventshemic and lymphatic diseasesMedicineClinical significancebusiness.industrylcsh:RC633-647.5Bone marrow failureHematologylcsh:Diseases of the blood and blood-forming organsEculizumabEculizumabmedicine.diseaseThrombosisparoxysmal nocturnal hemoglo-binuria thrombotic events renal failure Eculizumab030104 developmental biologyParoxysmal nocturnal hemoglobinuriabusinessmedicine.drug
researchProduct

Benign nocturnal alternating hemiplegia of childhood

2018

Objective: To describe the clinical spectrum of benign nocturnal alternating hemiplegia of childhood (BNAHC) including long-term follow-up data of previously published cases and to propose an underlying genetic cause of this disorder. Methods: We studied the medical data of two novel patients, reviewed the literature on BNAHC, and gathered information of the most recent follow-up of published cases regarding the course of episodes, further development, attempted drugs, ancillary investigations, and sequelae. Results: All patients, i.e. two novel cases and twelve patients identified in the literature (13 boys, 1 girl, age at onset four months to three years), experienced episodes of hemipleg…

0301 basic medicineMaleExome sequencingPediatricsmedicine.medical_specialtyHeterozygoteHemiplegiaNerve Tissue ProteinsPATIENTSensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]03 medical and health sciences0302 clinical medicinePRRT2 MUTATIONSmedicineHumansIctalPAROXYSMAL KINESIGENIC DYSKINESIAFamily historyPRRT2 geneExome sequencingCryingbusiness.industryAlternating hemiplegia of childhoodInfantMembrane ProteinsGeneral MedicineParoxysmal dyskinesiamedicine.diseaseDisorders of movement Donders Center for Medical Neuroscience [Radboudumc 3]GENESleep deprivation030104 developmental biologyPhenotypeTreatment OutcomeSYNAPTIC-TRANSMISSIONMigraineMIGRAINEChild PreschoolPediatrics Perinatology and Child HealthDisease ProgressionNeurology (clinical)medicine.symptombusinessINFANTILE CONVULSIONS030217 neurology & neurosurgeryGene DeletionBenign nocturnal alternating hemiplegia of childhoodEuropean Journal of Paediatric Neurology
researchProduct

PRRT2 gene variant in a child with dysmorphic features, congenital microcephaly, and severe epileptic seizures: genotype-phenotype correlation?

2019

Abstract Background Mutations in Proline-rich Transmembrane Protein 2 (PRRT2) have been primarily associated with individuals presenting with infantile epilepsy, including benign familial infantile epilepsy, benign infantile epilepsy, and benign myoclonus of early infancy, and/or with dyskinetic paroxysms such as paroxysmal kinesigenic dyskinesia, paroxysmal non-kinesigenic dyskinesia, and exercise-induced dyskinesia. However, the clinical manifestations of this disorder vary widely. PRRT2 encodes a protein expressed in the central nervous system that is mainly localized in the pre-synaptic neurons and is involved in the modulation of synaptic neurotransmitter release. The anomalous functio…

0301 basic medicineMaleMicrocephalyMutation MissenseCase ReportNerve Tissue ProteinsBioinformaticsRisk AssessmentSeverity of Illness Index03 medical and health sciences0302 clinical medicineRare DiseasesSeizuresmedicineHumansGenetic Predisposition to DiseaseGenetic TestingExome sequencingGenetic Association StudiesBenign familial infantile epilepsyDysmorphic featuresbusiness.industryEpileptic encephalopathylcsh:RJ1-570InfantMembrane Proteinslcsh:PediatricsParoxysmal dyskinesiamedicine.diseaseBody Dysmorphic DisordersPrognosisPRRT2 mutationMagnetic Resonance Imaging030104 developmental biologyDyskinesiaMicrocephalymedicine.symptomPRRT2 mutation Dysmorphic features Microcephaly Epileptic encephalopathybusinessMyoclonus030217 neurology & neurosurgeryPRRT2Benign infantile epilepsy
researchProduct

PRRT2 mutations are the major cause of benign familial infantile seizures.

2012

Mutations in PRRT2 have been described in paroxysmal kinesigenic dyskinesia (PKD) and infantile convulsions with choreoathetosis (PKD with infantile seizures), and recently also in some families with benign familial infantile seizures (BFIS) alone. We analyzed PRRT2 in 49 families and three sporadic cases with BFIS only of Italian, German, Turkish, and Japanese origin and identified the previously described mutation c.649dupC in an unstable series of nine cytosines to occur in 39 of our families and one sporadic case (77% of index cases). Furthermore, three novel mutations were found in three other families, whereas 17% of our index cases did not show PRRT2 mutations, including a large fami…

AdultMaleAdolescentChoreoathetosisNerve Tissue ProteinsBiologymedicine.disease_causeSeizures FebrileInfantile seizures03 medical and health sciencesEpilepsy0302 clinical medicineGeneticsmedicineHumansChildGenetics (clinical)030304 developmental biologyAgedGenetics0303 health sciencesMutationBenign familial infantile epilepsyEpilepsyPRRT2; EpilepsyInfantMembrane ProteinsParoxysmal dyskinesiaMiddle Agedmedicine.diseaseMajor genePedigreeChild PreschoolMutationPRRT2medicine.symptomSpasms Infantile030217 neurology & neurosurgeryPRRT2Human mutation
researchProduct

Biologic relevance of elevated red cell adenosine deaminase activity in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria.

1992

Red cell adenosine deaminase (ADA-RBC) activity in patients with myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria is significantly increased compared to that observed in normal controls. ADA-RBC activity is not related to fetal hemoglobin concentration, but it is significantly correlated with hemoglobin concentration at diagnosis and with the degree of morphologic dysplasia in the erythroid lineage. The results of our study suggest that the observed enzymatic abnormality may constitute a non-specific manifestation of the stem cell alteration that determines these disorders.

AdultMaleCancer Researchmedicine.medical_specialtyErythrocytesAdenosine DeaminaseHemoglobinuria Paroxysmal030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineAdenosine deaminaseInternal medicineFetal hemoglobinmedicineHumansPreleukemiaAgedRed Cellbiologybusiness.industryMyelodysplastic syndromeshemic and immune systemsGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologyOncologyDysplasia030220 oncology & carcinogenesisMyelodysplastic Syndromesbiology.proteinParoxysmal nocturnal hemoglobinuriaElevated red cell adenosine deaminase activityFemaleHemoglobinbusinessTumori
researchProduct

Intermediate nerve schwannoma: A rare tumour

2011

The intermediate nerve (IN), also called the nerve of Wrisberg, is a relatively small nerve with a variable anatomical course. Currently, this nerve is not addressed well in the pertinent literature. Pre-operative diagnosis of IN tumours is clinically challenging due to the lack of related symptoms. Symptoms are typically caused by the functional deterioration of neighbouring anatomical structures. In this report, we describe a patient with a schwannoma that arose at the porus acusticus of the internal auditory canal; during surgery, this proved to originate from the IN. We discuss our findings in the context of previously reported cases of IN schwannomas and analyse the vague characteristi…

AdultMaleSchwannomaMagnetic Resonance ImagingNerve of WrisbergDiagnosis DifferentialFacial NerveVestibular schwannomaIntermediate nerveVertigoHumansCranial Nerve NeoplasmsBenign Paroxysmal Positional VertigoFacial Nerve DiseasesNeurilemmoma
researchProduct

Benign paroxysmal positional vertigo following whiplash injury: a myth or a reality?

2011

Abstract Objective The aim of the study was to evaluate the true incidence, diagnosis, and treatment of benign paroxysmal positional vertigo (BPPV) arising after whiplash injury and to distinguish this type of posttraumatic vertigo from other types of dizziness complained after trauma. Methods This was a retrospective study comprising patients referred to our center after whiplash injury. The patients were evaluated with neurotologic examination including bedside and instrumental tests. A Dizziness Handicap Inventory evaluating the symptoms of patients was submitted before and after treatment and was evaluated. The BPPV patients were separately evaluated from those with cervicogenic vertigo…

AdultMalemedicine.medical_specialtyBenign paroxysmal positional vertigoAdolescentPoison controlPositional vertigo whiplash injuryNystagmusPatient PositioningYoung AdultPhysical medicine and rehabilitationNystagmus PhysiologicRecurrenceVertigootorhinolaryngologic diseasesmedicineWhiplashHumansBenign Paroxysmal Positional VertigoWhiplash InjuriesAgedRetrospective StudiesVestibular systemTrauma Severity IndicesbiologyPosterior Semicircular Canalbusiness.industryRetrospective cohort studyMiddle AgedPrognosisbiology.organism_classificationmedicine.diseaseSemicircular CanalsOtorhinolaryngologyVertigoPhysical therapyFemalesense organsmedicine.symptombusinessFollow-Up Studies
researchProduct

Are postural restrictions necessary for management of posterior canal benign paroxysmal positional vertigo?

2011

Objectives: An important component of management of benign paroxysmal positional vertigo (BPPV) has been the application of postural restrictions after use of a canalith repositioning maneuver (CRM) to prevent the return of otolithic debris into the posterior semicircular canal (PSC). This study was designed to explore the effectiveness of postural restrictions in patients with BPPV caused by otolithic debris in the PSC. Methods: Seventy-four adult patients with unilateral PSC BPPV were enrolled into this study. All patients were managed with a CRM — Either the modified Epley maneuver or the Semont maneuver. The patients were divided randomly into 2 groups: Group A, with postural restrictio…

AdultMalemedicine.medical_specialtyBenign paroxysmal positional vertigoAdolescentmedicine.medical_treatmentPostureEpley maneuverlaw.inventionSemont maneuverYoung AdultPhysical medicine and rehabilitationPosterior canal vertigoRandomized controlled triallawPostural restrictionRecurrenceVertigomedicineHumansEpley maneuverBenign Paroxysmal Positional VertigoProspective StudiesProspective cohort studyAgedSemont maneuverAged 80 and overAdult patientsbiologyPosterior Semicircular Canalbusiness.industryGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationBPPVSurgeryTreatment OutcomeOtorhinolaryngologyVertigoFemalebusinessThe Annals of otology, rhinology, and laryngology
researchProduct

Management of benign paroxysmal positional vertigo of lateral semicircular canal by Gufoni's manoeuvre

2009

Abstract Benign paroxysmal positional vertigo (BPPV) of lateral semicircular canal (LSC) is one of the rarer forms of BPPV as compared to posterior semicircular canal BPPV. Various particle repositioning manoeuvres have been described in the literature as a mode of treating this condition. Purpose Evaluation and discussion of the procedure of the Gufoni's manoeuvre and its advantages in the treatment of BPPV of LSC. Material and methods Prospective study of 58 patients affected by LSC BPPV who were office-treated with Gufoni's manoeuvre. Results Seventy-nine percent of the patients so treated had complete resolution of symptoms, and 6.9% did not show any improvement in their symptoms. The r…

AdultMalemedicine.medical_specialtyBenign paroxysmal positional vertigoGufoni's manoeuvre lateral semicircular canal paroxysmal positional vertigoOffice VisitsOffice visitsVertigoAmbulatory Careotorhinolaryngologic diseasesmedicineHumansProspective StudiesAgedAged 80 and overSemicircular canalbiologyPosterior Semicircular Canalbusiness.industryFollow up studiesMiddle Agedmedicine.diseasebiology.organism_classificationMusculoskeletal ManipulationsComplete resolutionSemicircular CanalsSurgeryTreatment Outcomemedicine.anatomical_structureOtorhinolaryngologyVertigoFemaleLateral semicircular canalsense organsbusinessFollow-Up StudiesAmerican Journal of Otolaryngology
researchProduct

Comparison of repositioning maneuvers for benign paroxysmal positional vertigo of posterior semicircular canal: advantages of hybrid maneuver.

2012

Objective: The prevalence of benign paroxysmal positional vertigo (BPPV) is becoming more frequent in elderly population. The presence of comorbid factors has to be considered before assessment as well as before commencing any repositioning treatment. Our aims were evaluation of the maneuvers efficacy and evaluation of the applicability of hybrid maneuver (HM) in patients with physical limitation. Study design and setting: This is a randomized study in 2 tertiary referral centers. Intervention: This is a therapeutic intervention. Patients: All consecutive patients with diagnosis of BPPV of posterior canal matching the inclusion criteria were enrolled. Patients underwent treatment soon after…

AdultMalemedicine.medical_specialtyBenign paroxysmal positional vertigoPostureNystagmusPatient Positioninglaw.inventionsymbols.namesakeRandomized controlled triallawElderly populationotorhinolaryngologic diseasesmedicineEffective treatmentHumansBenign Paroxysmal Positional VertigoFisher's exact testAgedRetrospective StudiesAged 80 and overPosterior Semicircular Canalbusiness.industryMiddle Agedmedicine.diseaseSemicircular CanalsSurgeryPhysical limitationsTreatment OutcomeOtorhinolaryngologysymbolsVertigoFemalemedicine.symptombusinessFollow-Up StudiesAmerican journal of otolaryngology
researchProduct